Galcanezumab OverviewGalcanezumab, marketed under the trade name Emgality, is a humanized monoclonal antibody used for the prevention of migraine. It is also used for cluster headaches. Common side effects include pain or redness at the site of injection. Other side effects may include hypersensitivity reactions. It is directed against calcitonin-related polypeptides alpha and beta. This drug was developed by Eli Lilly....
Read more Galcanezumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Galcanezumab
Recent Galcanezumab Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 120mg/ml
Other drugs which contain Galcanezumab or a similar ingredient: (1 result)
- EMGALITY Galcanezumab-gnlm